Fibrosis: therapeutic target or inevitable outcome?
00:00 EST 22 Feb 2013 | New York Academy of Sciences
Event Information: Tuesday, October 22, 2013 | 8:30 AM - 4:30 P
Fibrosis is common in chronic organ injury, leading to progressive life-threatening outcomes. We review the link between fibrosis and disease and explore ways to use biomarkers and imaging to translate laboratory results into clinical success.
Original Article: Fibrosis: therapeutic target or inevitable outcome?
More From BioPortfolio on "Fibrosis: therapeutic target or inevitable outcome?"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
